Bleeding disorders are a group of conditions in which there is a problem with the body's blood clotting process. These disorders can lead to heavy and prolonged bleeding after an injury. Bleeding can also begin on its own.
Specific bleeding disorders include:
- Acquired platelet function defects
- Congenital platelet function defects
- Disseminated intravascular coagulation (DIC)
- Prothrombin deficiency
- Factor V deficiency
- Factor VII deficiency
- Factor X deficiency
- Factor XI deficiency (hemophilia C)
- Glanzmann disease
- Hemophilia A
- Hemophilia B
- Idiopathic thrombocytopenic purpura (ITP)
- Von Willebrand disease (types I, II, and III)
Normal blood clotting involves blood components, called platelets, and as many as 20 different plasma proteins. These are known as blood clotting or coagulation factors. These factors interact with other chemicals to form a substance that stops bleeding called fibrin.
Problems can occur when certain factors are low or missing. Bleeding problems can range from mild to severe.
Some bleeding disorders are present at birth and are passed down through families (inherited). Others develop from:
- Illnesses, such as vitamin K deficiency or severe liver disease
- Treatments, such as the use of drugs to stop blood clots (anticoagulants) or the long-term use of antibiotics
Bleeding disorders can also result from a problem with the number or function of the blood cells that promote blood clotting (platelets). These disorders can also be either inherited or develop later (acquired). The side effects of certain drugs often lead to the acquired forms.
Symptoms may include any of the following:
- Bleeding into joints or muscles
- Bruising easily
- Heavy bleeding
- Heavy menstrual bleeding
- Nosebleeds that do not stop easily
- Excessive bleeding with surgical procedures
- Umbilical cord bleeding after birth
The problems that occur depend on the specific bleeding disorder, and how severe it is.
Exams and Tests
Tests that may be done include:
- Complete blood count (CBC)
- Partial thromboplastin time (PTT)
- Platelet aggregation test
- Prothrombin time (PT)
- Mixing study, a special PTT test to confirm the factor deficiency
Treatment depends on the type of disorder. It may include:
- Clotting factor replacement
- Fresh frozen plasma transfusion
- Platelet transfusion
- Other treatments
Find out more about bleeding disorders through these groups:
- National Hemophilia Foundation: Other Factor Deficiencies -- www.hemophilia.org/Bleeding-Disorders/Types-of-Bleeding-Disorders/Other-Factor-Deficiencies
- National Hemophilia Foundation: Victory for Women with Blood Disorders -- www.hemophilia.org/Community-Resources/Women-with-Bleeding-Disorders/Victory-for-Women-with-Blood-Disorders
- US Department of Health and Human Services -- www.womenshealth.gov/a-z-topics/bleeding-disorders
Outcome also depends on the disorder. Most primary bleeding disorders can be managed. When the disorder is due to diseases, such as DIC, the outcome will depend on how well the underlying disease can be treated.
Complications may include:
- Bleeding in the brain
- Severe bleeding (usually from the gastrointestinal tract or injuries)
Other complications can occur, depending on the disorder.
When to Contact a Medical Professional
Call your health care provider if you notice any unusual or severe bleeding.
Prevention depends on the specific disorder.
Gailani D, Wheeler AP, Neff AT. Rare coagulation factor deficiencies. In: Hoffman R, Benz EJ, Silberstein LE, et al, eds. Hematology: Basic Principles and Practice. 7th ed. Philadelphia, PA: Elsevier; 2018:chap 137.
Hall JE. Hemostasis and blood coagulation. In: Hall JE, ed. Guyton and Hall Textbook of Medical Physiology. 13th ed. Philadelphia, PA: Elsevier; 2016:chap 37.
Nichols WL. Von Willebrand disease and hemorrhagic abnormalities of platelet and vascular function. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 25th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 173.
Ragni MV. Hemorrhagic disorders: coagulation factor deficiencies. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 25th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 174.
Review Date: 1/29/2019
Reviewed By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.